ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

Duke recruits Judd Moul as chief of urology.

July 9, 2004

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

Karmanos Cancer Institute, CDC, Blue Cross To Begin Environmental Cancer Program

June 4, 2010

Methylene Chloride Mortality Study Approved By DCE board

June 27, 1986

House Panel Recommends $642 Million Increase For NIH; $31 Million Increase For NCI

July 21, 1995